Message from the CEO
Read a letter from our CEO, Robert Blum, outlining the many exciting opportunities for Cytokinetics in the next few years.
Latest News
- Aug 27, 2008 Cytokinetics Announces Completion of Interim Safety Analysis in Ongoing Phase IIa Clinical Trial of CK-1827452
- Aug 25, 2008 Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the European Society of Cardiology Congress 2008
- Jul 31, 2008 Cytokinetics, Incorporated Reports Second Quarter 2008 Financial Results
- View all news
Scientific Publications
Learn about Cytokinetics’ extensive scientific and medical publications related to our pipeline products and our research.
Events
July 31, 2008
Q2 2008 Cytokinetics, Inc.
Earnings Conference Call
Webcast begins at 4:30 p.m. ET
Interim Results of a Phase IIa Clinical Trial of CK-1827452 in Stable Heart Failure Patients
Webcast begins at 7:00 a.m. ET